• Explore /
  • Poster
  • / Safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (Neo DCF) therapy for locally advanced esophageal cancer: Real world data analysis.

Safety and efficacy of neoadjuvant docetaxel, cisplatin, and 5-fluorouracil (Neo DCF) therapy for locally advanced esophageal cancer: Real world data analysis.

Abstract Poster

Authors

null

Mikako Tamba

Cancer Institute Hospital, Japanese Foundation for Cancer Research, Tokyo, Japan

Mikako Tamba , Hiroki Osumi , Shota Fukuoka , Mariko Ogura , Akihiko Okamura , Jun Kanamori , Yu Imamura , Daisuke Takahari , Koichiro Yoshino , Shohei Udagawa , Takeru Wakatsuki , Eiji Shinozaki , Masayuki Watanabe , Kensei Yamaguchi , Keisho Chin , Akira Ooki

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2024 ASCO Gastrointestinal Cancers Symposium

Session Type

Poster Session

Session Title

Poster Session A: Cancers of the Esophagus and Stomach and Other Gastrointestinal Cancers

Track

Esophageal and Gastric Cancer,Other GI Cancer

Sub Track

Therapeutics

Citation

J Clin Oncol 42, 2024 (suppl 3; abstr 365)

DOI

10.1200/JCO.2024.42.3_suppl.365

Abstract #

365

Poster Bd #

H7

Abstract Disclosures

Similar Posters

First Author: Toshiharu Hirose

First Author: Mashiro Okunaka

First Author: Takako Yoshii

Poster

2024 ASCO Gastrointestinal Cancers Symposium

Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.

Safety and efficacy of nanosomal docetaxel lipid suspension (NDLS) in patients with advanced gastric adenocarcinoma.

First Author: Vikas S. Ostwal